Cigna Corporation (CI): Price and Financial Metrics
Cigna Corporation (CI)
Today's Latest Price: $218.49 USD
Updated Jan 25 3:09pm
Add CI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 8 in Medical - Health Insurance
See all "A" rated Strong Buy stocks
CI Stock Summary
- CI has a higher market value than 97.23% of US stocks; more precisely, its current market capitalization is $80,714,335,698.
- Cigna Corp's stock had its IPO on January 1, 1986, making it an older stock than 92.81% of US equities in our set.
- CI's price/sales ratio is 0.51; that's higher than the P/S ratio of just 12.14% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Cigna Corp are MDLZ, ANTM, BKNG, INFY, and TJX.
- Visit CI's SEC page to see the company's official filings. To visit the company's web site, go to www.cigna.com.
CI Stock Price Chart Interactive Chart >
CI Price/Volume Stats
| Current price | $218.49 | 52-week high | $230.90 |
| Prev. close | $223.42 | 52-week low | $118.50 |
| Day low | $217.16 | Volume | 1,255,884 |
| Day high | $222.23 | Avg. volume | 1,914,133 |
| 50-day MA | $211.84 | Dividend yield | 0.02% |
| 200-day MA | $190.06 | Market Cap | 78.93B |
Cigna Corporation (CI) Company Bio
Cigna Corporation offers medical, dental, disability, life and accident insurance and related products and services. The Company operates in three segments: Global Health-Care, Global Supplemental Benefits and Group Disability and Life. The company was founded in 1792 and is based in Bloomfield, Connecticut.
CI Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $218.49 | $755.95 | 238% |
We started the process of determining a valid price forecast for Cigna Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Cigna Corp ranked in the 76th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 240% on a DCF basis. As for the metrics that stood out in our discounted cash flow analysis of Cigna Corp, consider:
- The stock's equity weight, or the proportion of capital from equity relative to debt, is 69. Its equity weight surpasses that of only 20.49% of free cash flow generating stocks in the Healthcare sector.
- Cigna Corp's weighted average cost of capital (WACC) is 8%; for context, that number is higher than only 7.39% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 232% |
| 1% | 235% |
| 2% | 238% |
| 3% | 242% |
| 4% | 245% |
| 5% | 248% |
SUPN, VTRS, SUWN, LHCG, and UHS can be thought of as valuation peers to CI, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...